• Li H.
• et al.

Mucosal or systemic microbiota exposures shape the B cell repertoire.

Nature. 2020; 584: 274-278

• Forthal D.N.

Functions of antibodies.

Microbiol. Spectr. 2014; 2: 1-17

• Bemark M.
• Angeletti D.

Know your enemy or find your friend? Induction of IgA at mucosal surfaces.

Immunol. Rev. 2021; ()

• Carter P.J.
• Lazar G.A.

Next generation antibody drugs: pursuit of the ’high-hanging fruit’.

Nat. Rev. Drug Discov. 2017; 17: 197-223

• Libster R.
• et al.

Early high-titer plasma therapy to prevent severe Covid-19 in older adults.

N. Engl. J. Med. 2021; 384: 610-618

• Vaisman-Mentesh A.
• et al.

Molecular landscape of anti-drug antibodies reveals the mechanism of the immune response following treatment with TNFα Antagonists.

Front. Immunol. 2019; 10: 2921

• Borrebaeck C.A.K.

Antibodies in diagnostics – from immunoassays to protein chips.

Immunol. Today. 2000; 21: 379-382

• Hillman Y.
• et al.

Monoclonal antibody-based biosensor for point-of-care detection of type III secretion system expressing pathogens.

Anal. Chem. 2021; 93: 928-935

• Schramm C.

AIRR-C Glossary of Terms.

zenodo. 2021; https://doi.org/10.5281/zenodo.5095380

• Wardemann H.
• Busse C.E.

Novel approaches to analyze immunoglobulin repertoires.

Trends Immunol. 2017; 38: 471-482

• Greiff V.
• et al.

Bioinformatic and statistical analysis of adaptive immune repertoires.

Trends Immunol. 2015; 36: 738-749

• Robinson W.H.

Sequencing the functional antibody repertoire – diagnostic and therapeutic discovery.

Nat. Rev. Rheumatol. 2014; 11: 171-182

• Mason D.M.
• et al.

Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning.

Nat. Biomed. Eng. 2021; 5: 600-612

• Galson J.D.
• et al.

Studying the antibody repertoire after vaccination: practical applications.

Trends Immunol. 2014; 35: 319-331

• Miho E.
• et al.

Computational strategies for dissecting the high-dimensional complexity of adaptive immune repertoires.

Front. Immunol. 2018; 9: 224

• Yaari G.
• Kleinstein S.H.

Practical guidelines for B-cell receptor repertoire sequencing analysis.

Genome Med. 2015; 7: 121

• Sato S.
• et al.

Proteomics-directed cloning of circulating antiviral human monoclonal antibodies.

Nat. Biotechnol. 2012; 30: 1039-1043

• Cheung W.C.
• et al.

A proteomics approach for the identification and cloning of monoclonal antibodies from serum.

Nat. Biotechnol. 2012; 30: 447-452

• Wine Y.
• et al.

Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire.

Curr. Opin. Immunol. 2015; 35: 89-97

• Nesvizhskii A.I.

Proteogenomics: concepts, applications and computational strategies.

Nat. Methods. 2014; 11: 1114-1125

• Lee J.
• et al.

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination.

Nat. Med. 2016; 22: 1456-1464

• Wine Y.
• et al.

Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response.

Proc. Natl. Acad. Sci. 2013; 110: 2993-2998

• Lavinder J.J.
• et al.

Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires.

Curr. Opin. Chem. Biol. 2015; 24: 112-120

• Chen J.
• et al.

Proteomic analysis of Pemphigus autoantibodies indicates a larger, more diverse, and more dynamic repertoire than determined by B cell genetics.

Cell Rep. 2017; 18: 237-247

• Iversen R.
• et al.

Strong clonal relatedness between serum and gut IgA despite different plasma cell origins.

Cell Rep. 2017; 20: 2357-2367

• Lindesmith L.C.
• et al.

Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination.

Immunity. 2019; 50: 1530-1541

• Xiang Y.
• et al.

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.

Science. 2020; 370: 1479-1484

• Lavinder J.J.
• et al.

Identification and characterization of the constituent human serum antibodies elicited by vaccination.

Proc. Natl. Acad. Sci. 2014; 111: 2259-2264

• Bondt A.
• et al.

Human Plasma IgG1 Repertoires Are Simple, Unique, and Dynamic.

Social Science Research Network, 2020

• Tomescu-Baciu A.
• et al.

Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.

J. Neuroimmunol. 2019; 333: 576966

• Lee J.
• et al.

Persistent antibody clonotypes dominate the serum response to influenza over multiple years and repeated vaccinations.

Cell Host Microbe. 2019; 25: 367-376

• Johansen J.N.
• et al.

Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.

Clin. Immunol. 2015; 160: 211-225

• Teraguchi S.
• et al.

Methods for sequence and structural analysis of B and T cell receptor repertoires.

Comput. Struct. Biotechnol. J. 2020; 18: 2000-2011

• Song M.K.
• et al.

Light chain of natural antibody plays a dominant role in protein antigen binding.

Biochem. Biophys. Res. Commun. 2000; 268: 390-394

• Chailyan A.
• et al.

The association of heavy and light chain variable domains in antibodies: implications for antigen specificity.

FEBS J. 2011; 278: 2858-2866

• Akbar R.
• et al.

A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding.

Cell Rep. 2021; 34: 108856

• Xiang Y.
• et al.

Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.

Cell Syst. 2021; 12: 220-234

• Voss W.N.
• et al.

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.

Science. 2021; 372: 1108-1112

• Benner R.
• et al.

‘Background’ immunoglobulin production: measurement, biological significance and regulation.

Immunol. Today. 1982; 3: 243-249

• Amanna I.J.
• et al.

Duration of humoral immunity to common viral and vaccine antigens.

N. Engl. J. Med. 2007; 357: 1903-1915

• Bachmann M.F.
• et al.

The role of antibody concentration and avidity in antiviral protection.

Science. 1997; 276: 2024-2027

• Bonissone S.R.
• et al.

Serum proteomics expands on high-affinity antibodies in immunized rabbits than deep B-cell repertoire sequencing alone.

BioRxiv. 2020; ()

• Curtis N.C.
• Lee J.

Beyond bulk single-chain sequencing: getting at the whole receptor.

Curr. Opin. Syst. Biol. 2020; 24: 93-99

• Iype J.
• et al.

Differences in self-recognition between secreted antibody and membrane-bound B cell antigen receptor.

J. Immunol. 2019; 202: 1417-1427

• Shi Z.
• et al.

More than one antibody of individual B cells revealed by single-cell immune profiling.

Cell Discov. 2019; 5 ()

• Safonova Y.
• et al.

IgRepertoireConstructor: a novel algorithm for antibody repertoire construction and immunoproteogenomics analysis.

Bioinformatics. 2015; 31: i53-i61

• Benner R.
• et al.

The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation.

Clin. Exp. Immunol. 1981; 46: 1-8

• Brown, A. J.
• et al.

Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires.

Mol. Syst. Des. Eng. 2019; 4: 701-736

• Friedensohn S.
• et al.

Advanced methodologies in high-throughput sequencing of immune repertoires.

Trends Biotechnol. 2016; 35: 203-214

• Setliff I.
• et al.

High-throughput mapping of B cell receptor sequences to antigen specificity.

Cell. 2019; 179: 1636-1646

• Shaw J.B.
• et al.

Direct determination of antibody chain pairing by top-down and middle-down mass spectrometry using electron capture dissociation and ultraviolet photodissociation.

Anal. Chem. 2020; 92: 766-773

Understanding the human antibody repertoire.

mAbs. 2020; 12: 1729683

• Robert P.A.
• Meyer-Hermann M.

A 3D structural affinity model for multi-epitope in silico germinal center simulations.

BioRxiv. 2019; ()

• Robert P.A.
• et al.

Induction of broadly neutralizing antibodies in germinal centre simulations.

Curr. Opin. Biotechnol. 2018; 51: 137-145

• Mayer A.
• et al.

How a well-adapted immune system is organized.

Proc. Natl. Acad. Sci. 2015; 112: 5950-5955

• Greiff V.
• et al.

A minimal model of peptide binding predicts ensemble properties of serum antibodies.

BMC Genomics. 2012; 13: 79

• Kanyavuz A.
• et al.

Breaking the law: unconventional strategies for antibody diversification.

Nat. Rev. Immunol. 2019; 19: 355-368

• Raybould M.I.J.
• et al.

Five computational developability guidelines for therapeutic antibody profiling.

Proc. Natl. Acad. Sci. U. S. A. 2019; 116: 4025-4030

• Pyzik M.
• et al.

The neonatal Fc receptor (FcRn): a misnomer?.

Front. Immunol. 2019; 10: 1540

• Hmiel L.K.
• et al.

Post-translational structural modifications of immunoglobulin G and their effect on biological activity.

Anal. Bioanal. Chem. 2015; 407: 79-94

• Larsen M.D.
• et al.

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.

Science. 2021; 371eabc8378

• Bournazos S.
• et al.

Antibody fucosylation predicts disease severity in secondary dengue infection.

Science. 2021; 372: 1102-1105

• Selman M.H.J.
• et al.

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Mol. Cell. Proteomics. 2012; 11M111.014563

• Alfaro J.A.
• et al.

The emerging landscape of single-molecule protein sequencing technologies.

Nat. Methods. 2021; 18: 604-617

• Timp W.
• Timp G.

Beyond mass spectrometry, the next step in proteomics.

Sci. Adv. 2020; 6eaax8978

• Corrie B.D.
• et al.

iReceptor: a platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories.

Immunol. Rev. 2018; 284: 24-41

• Hershberg U.
• Prak E.T.L.

The analysis of clonal expansions in normal and autoimmune B cell repertoires.

Philos. Trans. R. Soc. B. 2015; 370: 20140239

• Khan T.A.
• et al.

Accurate and predictive antibody repertoire profiling by molecular amplification fingerprinting.

Sci. Adv. 2016; 2e1501371

• Zhang Y.
• et al.

Protein analysis by shotgun/bottom-up proteomics.

Chem. Rev. 2013; 113: 2343-2394

• Finoulst I.
• et al.

Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices.

J. Biomed. Biotechnol. 2011; 2011e245291

• Fishman J.B.
• Berg E.A.

Protein A and protein G purification of antibodies.

Cold Spring Harb. Protoc. 2019; 2019prot099143

• Grodzki A.C.
• Berenstein E.

Antibody purification: ammonium sulfate fractionation or gel filtration.

in: Oliver C. Jamur M.C. Immunocytochemical Methods and Protocols. Humana Press, 2010: 15-26

• Singh N.
• Singh N.

Blood plasma from survivors of COVID-19: a novel and next frontier approach to fight against pandemic coronavirus.

Int. J. Immunol. Immunother. 2020; 7: 045

• Boutz D.R.
• et al.

Proteomic identification of monoclonal antibodies from serum.

Anal. Chem. 2014; 86: 4758-4766

• Gillet L.C.
• et al.

Mass spectrometry applied to bottom-up proteomics: entering the high-throughput era for hypothesis testing.

Annu. Rev. Anal. Chem. 2016; 9: 449-472

• Swaney D.L.
• et al.

Value of using multiple proteases for large-scale mass spectrometry-based proteomics.

J. Proteome Res. 2010; 9: 1323-1329

• Mora T.
• et al.

Maximum entropy models for antibody diversity.

Proc. Natl. Acad. Sci. 2010; 107: 5405-5410

• Tsiatsiani L.
• Heck A.J.R.

Proteomics beyond trypsin.

FEBS J. 2015; 282: 2612-2626

• Srzentić K.
• et al.

Interlaboratory study for characterizing monoclonal antibodies by top-down and middle-down mass spectrometry.

J. Am. Soc. Mass Spectrom. 2020; 31: 1783-1802

• Foote J.
• Eisen H.N.

Breaking the affinity ceiling for antibodies and T cell receptors.

Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 10679-10681

• Bache N.
• et al.

A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics.

Mol. Cell. Proteomics. 2018; 17: 2284-2296

• Keshishian H.
• et al.

Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.

Mol. Cell. Proteomics. 2015; 14: 2375-2393

• Qian W.-J.
• et al.

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity aeparation atrategy.

Mol. Cell. Proteomics. 2008; 7: 1963-1973

• Blume J.E.
• et al.

Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona.

Nat. Commun. 2020; 11: 3662

• Meier F.
• et al.

Online parallel accumulation–serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer.

Mol. Cell. Proteomics. 2018; 17: 2534-2545

• Hebert A.S.
• et al.

Comprehensive single-shot proteomics with FAIMS on a hybrid orbitrap mass spectrometer.

Anal. Chem. 2018; 90: 9529-9537

• Meier F.
• et al.

BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes.

Nat. Methods. 2018; 15: 440-448

• Messner C.B.
• et al.

Ultra-fast proteomics with scanning SWATH.

Nat. Biotechnol. 2021; 39: 846-854

• Ludwig C.
• et al.

Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial.

Mol. Syst. Biol. 2018; 14e8126

• Li J.
• et al.

TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples.

Nat. Methods. 2020; 17: 399-404

• Geyer P.E.
• et al.

Plasma proteome profiling to assess human health and disease.

Cell Syst. 2016; 2: 185-195

• Bruderer R.
• et al.

Analysis of 1508 plasma samples by capillary-flow data-independent acquisition profiles proteomics of weight loss and maintenance.

Mol. Cell. Proteomics. 2019; 18: 1242-1254

• Hein M.Y.
• et al.

A human interactome in three quantitative dimensions organized by stoichiometries and abundances.

Cell. 2015; 163: 712-723

• Huttlin E.L.
• et al.

The BioPlex network: a systematic exploration of the human interactome.

Cell. 2015; 162: 425-440

• Cox J.
• Mann M.

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Nat. Biotechnol. 2008; 26: 1367-1372

• Ma B.
• et al.

PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry.

Rapid Commun. Mass Spectrom. 2003; 17: 2337-2342

• Kim S.
• Pevzner P.A.

MS-GF+ makes progress towards a universal database search tool for proteomics.

Nat. Commun. 2014; 5: 5277

• Kong A.T.
• et al.

MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics.

Nat. Methods. 2017; 14: 513-520

• Orsburn B.C.

Proteome Discoverer – a community enhanced data processing suite for protein informatics.

Proteomes. 2021; 9: 15

• Avram O.
• et al.

PASA: proteomic analysis of serum antibodies web server.

PLoS Comput. Biol. 2021; 17e1008607

• Tran N.H.
• et al.

Complete de novo assembly of monoclonal antibody sequences.

Sci. Rep. 2016; 6: 31730

• Collins B.C.
• et al.

Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.

Nat. Commun. 2017; 8: 291

• Navarro P.
• et al.

A multicenter study benchmarks software tools for label-free proteome quantification.

Nat. Biotechnol. 2016; 34: 1130-1136

• Colaert N.
• et al.

Analysis of the resolution limitations of peptide identification algorithms.

J. Proteome Res. 2011; 10: 5555-5561

• Čaval T.
• et al.

The lysosomal endopeptidases Cathepsin D and L are selective and effective proteases for the middle-down characterization of antibodies.

FEBS J. 2021; ()

• Greisch J.-F.
• et al.

Generating informative sequence tags from antigen-binding regions of heavily glycosylated IgA1 antibodies by native top-down electron capture dissociation.

J. Am. Soc. Mass Spectrom. 2021; 32: 1326-1335

• Greiff V.
• et al.

Mining adaptive immune receptor repertoires for biological and clinical information using machine learning.

Curr. Opin. Syst. Biol. 2020; 24: 109-119

• Elhanati Y.
• et al.

Inferring processes underlying B-cell repertoire diversity.

Philos. Trans. R. Soc. B. 2015; 370: 20140243

• Greiff V.
• et al.

Learning the high-dimensional immunogenomic features that predict public and private antibody repertoires.

J. Immunol. 2017; 199: 2985-2997

• Collins A.M.
• et al.

Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?.

Curr. Opin. Syst. Biol. 2020; 24: 100-108

• Watson C.T.
• et al.

The individual and population genetics of antibody immunity.

Trends Immunol. 2017; 38: 459-470

• Xu J.L.
• Davis M.M.

Diversity in the CDR3 region of VH is sufficient for most antibody specificities.

Immunity. 2000; 13: 37-45

• Glanville J.
• et al.

Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire.

Proc. Natl. Acad. Sci. U. S. A. 2009; 06: 20216-20221

Number and distribution of lymphocytes in man. A critical analysis.

J. Mol. Med. 1974; 52: 511-515

• Nutt S.L.
• et al.

The generation of antibody-secreting plasma cells.

Nat. Rev. Immunol. 2015; 15: 160-171

• Helmreich E.
• et al.

The secretion of antibody by isolated lymph node cells.

J. Biol. Chem. 1961; 236: 464

• Eyer K.
• et al.

Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring.

Nat. Biotechnol. 2017; 35: 977-982

• Cerutti A.
• et al.

Immunoglobulin responses at the mucosal interface.

Annu. Rev. Immunol. 2011; 29: 273-293

• Manz R.A.
• et al.

Maintenance of serum antibody levels.

Annu. Rev. Immunol. 2005; 23: 367-386

• Vieira P.
• Rajewsky K.

The half-lives of serum immunoglobulins in adult mice.

Eur. J. Immunol. 1988; 18: 313-316

• Datta-Mannan A.
• et al.

Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics.

mAbs. 2015; 7: 483-493

• Schoch A.
• et al.

Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics.

Proc. Natl. Acad. Sci. U. S. A. 2015; 112: 5997-6002

• Sikorski K.
• et al.

A high-throughput pipeline for validation of antibodies.

Nat. Methods. 2018; 15: 909

• Larman H.B.
• et al.

Autoantigen discovery with a synthetic human peptidome.

Nat. Biotechnol. 2011; 29: 535-541

• Kunik V.
• Ofran Y.

The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops.

Protein Eng. Des. Sel. 2013; 26: 599-609

• Georgiev I.S.
• et al.

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.

Science. 2013; 340: 751-756

One by one – insights into complex immune responses through functional single-cell analysis.

Chim. Int. J. Chem. 2020; 74: 716-723

• Kräutler N.J.
• et al.

Quantitative and qualitative analysis of humoral immunity reveals continued and personalized evolution in chronic viral infection.

Cell Rep. 2020; 30: 997-1012

• Gérard A.
• et al.

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.

Nat. Biotechnol. 2020; 38: 715-721

• Cui W.
• et al.

Top-down mass spectrometry: recent developments, applications and perspectives.

Analyst. 2011; 136: 3854-3864

• Gregorich Z.R.
• et al.

Proteomics in heart failure: top-down or bottom-up?.

Pflugers Arch. 2014; 466: 1199-1209

• Catherman A.D.
• et al.

Top down proteomics: facts and perspectives.

Biochem. Biophys. Res. Commun. 2014; 445: 683-693

• Kachuk C.
• Doucette A.A.

The benefits (and misfortunes) of SDS in top-down proteomics.

J. Proteome. 2018; 175: 75-86

• Vasicek L.A.
• et al.

Direct quantitation of therapeutic antibodies for pharmacokinetic studies using immuno-purification and intact mass analysis.

Bioanalysis. 2019; ()

• Chen B.
• et al.

Top-down proteomics: ready for prime time?.

Anal. Chem. Wash. 2018; 90: 110-127

• Wang Z.
• et al.

Top-down mass spectrometry analysis of human serum autoantibody antigen-binding fragments.

Sci. Rep. 2019; 9: 2345

• Kellie J.F.
• et al.

A whole-molecule immunocapture LC–MS approach for the in vivo quantitation of biotherapeutics.

Bioanalysis. 2016; 8: 2103-2114

• Lanshoeft C.
• et al.

Generic hybrid ligand binding assay liquid chromatography high-resolution mass spectrometry-based workflow for multiplexed human immunoglobulin G1 quantification at the intact protein level: application to preclinical pharmacokinetic studies.

Anal. Chem. 2017; 89: 2628-2635

• Boer M.A. den
• et al.

Selectivity over coverage in de novo sequencing of IgGs.

Chem. Sci. 2020; 11: 11886-11896

• Nyman T.A.
• et al.

Mass spectrometry-based proteomic exploration of the human immune system: focus on the inflammasome, global protein secretion, and T cells.

Expert Rev. Proteomics. 2017; 14: 395-407

• An B.
• et al.

Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.

Drug Metab. Dispos. 2014; 42: 1858-1866

• Frank A.
• Pevzner P.

PepNovo: de novo peptide sequencing via probabilistic network modeling.

Anal. Chem. 2005; 77: 964-973

• Fischer B.
• et al.

NovoHMM: a hidden Markov model for de novo peptide sequencing.

Anal. Chem. 2005; 77: 7265-7273

• Guthals A.
• et al.

Sequencing-grade de novo analysis of MS/MS triplets (CID/HCD/ETD) from overlapping peptides.

J. Proteome Res. 2013; 12: 2846-2857

• Bandeira N.
• et al.

Automated de novo protein sequencing of monoclonal antibodies.

Nat. Biotechnol. 2008; 26: 1336-1338